Back
Immuneering Corp - Ordinary Shares Class A Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
IMRX
Immuneering Corp - Ordinary Shares Class A
Last Price:
$3.03
Seasonality Move:
39.93%
7 Day Trial
ALL ACCESS PASS
$
7
Immuneering Corp - Ordinary Shares Class A Stock Forecast
-
Is Immuneering Corp - Ordinary Shares Class A Stock Undervalued?The current Immuneering Corp - Ordinary Shares Class A [IMRX] share price is $3.22. The Score for IMRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
IMRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Immuneering Corp - Ordinary Shares Class A Stock Go Up Next Year?
Data Unavailable
Immuneering Corp - Ordinary Shares Class A Stock Rating
Data Unavailable
Immuneering Corp - Ordinary Shares Class A Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immuneering.com
52-Week Data
52-Week High:
4.69
52-Week Low:
1.00
Prediction Charts
Market Cap:
115.9M
Price in USD:
3.22
Volume:
213K
Beta:
0.38
Technical Analysis
SMA50:
3.29
SMA100:
2.36
SMA200:
2.14
52-Wk Change:
182.46%
Stock Predictions
-
Is Immuneering Corp - Ordinary Shares Class A stock public?Yes, Immuneering Corp - Ordinary Shares Class A is a publicly traded company.
-
What is the Immuneering Corp - Ordinary Shares Class A stock quote today?The Immuneering Corp - Ordinary Shares Class A stock price is 3.22 USD today.
-
How to buy Immuneering Corp - Ordinary Shares Class A stock online?You can buy Immuneering Corp - Ordinary Shares Class A shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jul-28 | 4.00 | 3.91 | 4.04 | 3.75 |
| Jul-29 | 3.97 | 3.68 | 3.97 | 3.61 |
| Jul-30 | 3.66 | 3.63 | 3.74 | 3.42 |
| Jul-31 | 3.61 | 3.44 | 3.67 | 3.43 |
| Aug-1 | 3.30 | 3.37 | 3.52 | 3.28 |
| Aug-4 | 3.26 | 3.43 | 3.45 | 3.25 |
| Aug-5 | 3.38 | 3.57 | 3.58 | 3.37 |
| Aug-6 | 3.60 | 3.52 | 3.62 | 3.41 |
| Aug-7 | 3.52 | 3.51 | 3.57 | 3.41 |
| Aug-8 | 3.52 | 3.25 | 3.53 | 3.24 |
| Aug-11 | 3.25 | 3.21 | 3.43 | 3.21 |
| Aug-12 | 3.24 | 3.25 | 3.25 | 3.04 |
| Aug-13 | 3.22 | 3.22 | 3.29 | 3.10 |
| Aug-14 | 3.18 | 3.04 | 3.18 | 2.90 |
Immuneering Corp - Ordinary Shares Class A Earnings
Data Unavailable
Immuneering Corp - Ordinary Shares Class A Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.14 per share, and an increase next year of $0.19 per share.
* Immuneering Corp - Ordinary Shares Class A stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.